Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sanofi Consumer Healthcare IndiaNSE:SANOFICONR -0.60%24 5-Year Yield-on-Cost % is 1.69 as of Aug. 17, 2026, which is 43% above its 10-year median of 1.18. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 509 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks worse than 57.96% on this metric.
The historical rank and industry rank for Sanofi Consumer Healthcare India's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:SANOFICONR'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.03 Med: 1.18 Max: 1.69
Current: 1.69
During the past 3 years, Sanofi Consumer Healthcare India's highest Yield on Cost was 1.69. The lowest was 1.03. And the median was 1.18.
NSE:SANOFICONR's 5-Year Yield-on-Cost % is ranked worse than 57.96% of 509
companies
in the Drug Manufacturers industry
Industry Median: 2.28
vs NSE:SANOFICONR: 1.69
Sanofi Consumer Healthcare India (NSE:SANOFICONR) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sanofi Consumer Healthcare India 5-Year Yield-on-Cost % Related Terms
NSE:SANOFICONR vs LLY, JNJ, ABBV: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi Consumer Healthcare India 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's 5-Year Yield-on-Cost % falls into.
Sanofi Consumer Healthcare India 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a 5-Year Yield-on-Cost % of 1.69 as of Aug. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sanofi Consumer Healthcare India and its competitors. This is 43% above median its historical median of 1.18. Over the past decade, Sanofi Consumer Healthcare India's 5-Year Yield-on-Cost % has ranged from 1.03 to 1.69. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #295 out of 509 companies in the Drug Manufacturers industry, placing it in the top 58%.
Is Sanofi Consumer Healthcare India's 5-Year Yield-on-Cost % too high?
Sanofi Consumer Healthcare India's current 5-Year Yield-on-Cost % of 1.69 is 43% above median its 10-year median of 1.18. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 1.69. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.28. Sanofi Consumer Healthcare India's value of 1.69 is 25.9% below this industry median. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #295 out of 509 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's 5-Year Yield-on-Cost % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #295 out of 509 companies for 5-Year Yield-on-Cost %. This places Sanofi Consumer Healthcare India in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.28. Sanofi Consumer Healthcare India's value of 1.69 is 25.9% below this benchmark. Historically, Sanofi Consumer Healthcare India's own 5-Year Yield-on-Cost % has ranged from 1.03 to 1.69 over the past decade. While the company's 10-year median is 1.18 vs. the industry median of 2.28, Sanofi Consumer Healthcare India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.28, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi Consumer Healthcare India's current 5-Year Yield-on-Cost % of 1.69 is 25.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current 5-Year Yield-on-Cost % is 1.69, which is 43% above median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current 5-Year Yield-on-Cost % of 1.69. The current 5-Year Yield-on-Cost % is 1.69, which is 43% above median its 10-year median of 1.18 and 25.9% below the Drug Manufacturers industry median of 2.28. Sanofi Consumer Healthcare India's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current 5-Year Yield-on-Cost % is 1.69 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
24GF Score
Get the complete analysis for NSE:SANOFICONR
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANOFICONR has been successfully added to your 
